TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 105 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -66.7% | 6,844 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +12.5% | 6,844 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -57.9% | 6,844 | 0.0% | 0.00% | – |
| Q3 2018 | $19,000 | -20.8% | 6,844 | 0.0% | 0.00% | – |
| Q2 2018 | $24,000 | -17.2% | 6,844 | -28.6% | 0.00% | – |
| Q1 2018 | $29,000 | -64.6% | 9,586 | -26.7% | 0.00% | – |
| Q4 2017 | $82,000 | -16.3% | 13,077 | -8.9% | 0.00% | – |
| Q3 2017 | $98,000 | +30.7% | 14,360 | +44.2% | 0.00% | – |
| Q2 2017 | $75,000 | -18.5% | 9,958 | 0.0% | 0.00% | – |
| Q1 2017 | $92,000 | +80.4% | 9,958 | -19.0% | 0.00% | – |
| Q4 2016 | $51,000 | +142.9% | 12,301 | +125.0% | 0.00% | – |
| Q3 2016 | $21,000 | -27.6% | 5,467 | -19.1% | 0.00% | – |
| Q2 2016 | $29,000 | -3.3% | 6,756 | 0.0% | 0.00% | – |
| Q1 2016 | $30,000 | -55.9% | 6,756 | 0.0% | 0.00% | – |
| Q4 2015 | $68,000 | +33.3% | 6,756 | 0.0% | 0.00% | – |
| Q3 2015 | $51,000 | -79.0% | 6,756 | +23.6% | 0.00% | – |
| Q2 2015 | $243,000 | +64.2% | 5,467 | +37.0% | 0.00% | – |
| Q1 2015 | $148,000 | -9.2% | 3,991 | 0.0% | 0.00% | – |
| Q4 2014 | $163,000 | +87.4% | 3,991 | -7.8% | 0.00% | – |
| Q3 2014 | $87,000 | – | 4,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |